¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"activated graft"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷À̽Ä
  • cartilage graft
    ¿¬°ñÀÌ½ÄÆí
  • chorioallantoic graft
    À¶¸ð¿ä¸·À̽Ä
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • free graft
    À¯¸®ÀÌ½ÄÆí
  • free jejunal graft
    À¯¸®ºóâÀÚÀ̽Ä(¼ú), À¯¸®°øÀåÀ̽Ä(¼ú)
  • full-thickness graft
    ÀüÃþÇǺÎÀ̽Ä
  • gauntlet graft
    Àå°©¸ð¾çÀ̽İñÆí
  • graft
    1. ÀÌ½Ä 2. ÀÌ½ÄÆí
  • graft atherosclerosis
    ÀÌ½ÄÆíÁ×°æÈ­(Áõ), ÀÌ½ÄÆíÁ׸ð¾ç°æÈ­(Áõ)
  • graft recipient
    1. ÀÌ½ÄÆí¹Þ´ÂÀÌ 2. ÀÌ½ÄÆí¹Þ´ÂºÎÀ§
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • heterodermic graft
    ÀÌÁ¾ÇǺÎÀ̽Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷À̽Ä
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • graft-versus-host disease
    À̽Ĵë¼÷ÁÖº´
  • free graft
    À¯¸®À̽Ä
  • free jejunal graft
    À¯¸®ºóâÀÚÀ̽ļú, À¯¸®°øÀåÀ̽ļú
  • full-thickness graft
    ÀüÃþÇǺÎÀ̽Ä
  • graft
    À̽Ä, ÀÌ½ÄÆí
  • gauntlet graft
    Àå°©¸ð¾çÀ̽İñÆí
  • graft recipient
    ÀÌ½ÄÆí¹Þ´ÂÀÌ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ
  • graft schizophrenia
    (¢¡propf schizophrenia) À̽ÄÁ¤½ÅºÐ¿­º´
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • heterodermic graft
    ÀÌÁ¾ÇǺÎÀ̽Ä
  • heteroplastic graft
    (¢¡xenograft) ÀÌÁ¾À̽Ä
  • heterotopic graft
    ´Ù¸¥ÀÚ¸®À̽Ä
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • graft
    Á¶Á÷À̽Ä(ðÚòÄì¹ãÕ)
  • graft =transplantation
    Á¶Á÷À̽Ä(ðÚòÄì¹ ãÕ), ÀÌ½ÄÆí(ì¹ãÕø¸).
  • graft accordion
    ¾ÆÄÚ¿Àµð¾ð½Ä ½ÄÇÇ(¡­½ÄÇÇ).
  • graft accordion
    ¾ÆÄÚ¿Àµð¾ð½Ä ½ÄÇÇ(¡­ãÕù«).
  • graft atherosclerosis
    À̽ÄÁ×»ó°æÈ­Áõ.
  • graft atherosclerosis
    À̽ÄÁ×»ó°æÈ­Áõ.
  • graft polymer
    À̽ÄÁßÇÕü.
  • graft recipient
    ÀÌ½ÄÆí¼ö·ÉÀÚ(ì¹ãÕø¸áôçÐíº).
  • graft recipient
    ÀÌ½ÄÆí¼ö·ÉÀÚ(ÀÌ½ÄÆí¼ö¿µÀÚ).
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ).
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
  • graft schizophrenia See schizophrenia
    Á¢Áö<Á¢¸ñ>Á¤½ÅºÐ¿­º´<Áõ> (ïÈò«<ïÈÙÊ>ïñãêÝÂæñÜ»<ñø>)
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bridging graft
    ±³·®À̽Ä(±³¾çÀ̽Ä).
  • bypass graft
    ȸ·ÎÁ¶¼º¼ú(ȸ·ÎÁ¶¼º¼ú), ¿ìȸ·ÎÀ̽Ä<Á¶¼º>¼ú.
  • bypass graft
    ¿ìȸ·Î À̽Ä(Á¶¼º)¼ú(éæüÞÖØì¹ãÕ[ðãà÷]âú).
  • cartilage graft
    ¿¬°ñÀ̽Ä
  • chorioallantoic graft
    À¶¸ð¿ä¸·À̽Ä(ëÖÙ¾èñدì¹ãÕ).
  • collagen graft
    ±³¿øÁúÀ̽Ä
  • composite graft
    º¹ÇÕÁ¶Á÷À̽Ä.
  • corneal graft
    °¢¸·ÀÌ½ÄÆí(¡­ì¹ãÖ).
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷ À̽Ä
  • dermic graft
    ½ÄÇÇ(½ÄÇÇ).
  • dermis graft
    ÁøÇÇÀ̽Ä
  • double-end graft
    ½Ö´ÜÀ̽Ä.
  • dural graft
    °æ¸·À̽Ä(°æ¸·À̽Ä).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
APTT, aPTT activated partial thromboplastin time
ATC activated thymus cell; around the clock
BaFBr:Eu europium-activated barium fluorohalide
BART blood-activated recalcification time
C1a activated first component of complement
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GvH Graft versus Host
GVH Graft versus host reaction
GVHR Graft versus host reaction
GVL Graft versus leukemia
GVHD Graft vs host disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inlay bone graft
    °¨ÀÔ °ñ À̽Ä
  • lamellar graft
    ÃþÆÇ À̽Ä
    ºÒÅõ¸íÇÑ °¢¸·ÀÇ Ç¥ÃþÀ» Á¦°ø ¾ÈÀÇ Åõ¸íÇÑ °¢¸·ÀÇ ¹ÚÃþ°ú ¹Ù²Ù´Â À̽Ä.
  • muscle graft
    ±ÙÀ° À̽Ä
  • Ollier-Thiersch graft
    ¿Ã¸®¿¡¸£ Ƽ¸£½¬ ÀÌ½ÄÆí
    »óÇÇÃþ, »óÇǸÁ, ÁøÇÇÀÇ ÀϺθ¦ Æ÷ÇÔÇÑ ¸Å¿ì ¾ã°í ³ÐÀº ÇǺΠÀÌ½ÄÆí.
  • omental graft
    ´ë¸Á À̽Ä
    ºÀÇÕ¼±À» µ¤±â À§ÇÏ¿© »ç¿ëµÇ´Â À¯¸®µÇ°Å³ª Àý´ÜµÇÁö ¾ÊÀº ´ë¸ÁÀÇ ºÐÀý. À§Àå ¹× °áÀå ¼ö¼ú ÈÄ¿¡ »ç¿ëµÈ´Ù.
  • onlay bone graft
    ÁßÃþ°ñ ÀÌ½ÄÆí
    ÇÇÀ̽ÄÀÚÀÇ ÇÇÁú¼º °ñ À§¿¡ µ¤´Â ÀÌ½ÄÆíÀ¸·Î¼­ÀÇ »À.
  • osseous graft
    °ñ À̽Ä, °ñ ÀÌ½ÄÆí
  • osteoperiosteal graft
    °ñ¸· À̽Ä
  • patch graft
    øºÎ ÀÌ½ÄÆí
    Ç÷°ü°­À» È®´ëÇϱâ À§ÇÏ¿© Ç÷°ü Àý°³ºÎ¸¦ ¸·´Â µ¥ »ç¿ëµÇ´Â À̽Ŀë Á¶Á÷ ¶Ç´Â ÀÎÁ¶ ¹°Áú.
  • pedicle graft
    °æ»ó ÀÌ½ÄÆí
  • penetrating graft
    °üÅë À̽Ä
    °¢¸·ÀÇ ÀüÃþ À̽Ä.
  • perichondral bony ring

    perichondral cutaneous graft

    ¿¬°ñ¸· ÇǺΠÀ̽Ä
  • periosteal graft
    °ñ¸· À̽Ä, °ñ¸· ÀÌ½ÄÆí
    °ñÀÇ ¹þ°ÜÁø ºÎÀ§¿¡ »ç¿ëµÇ´Â °ñ¸·Æí.
  • Phemister graft
    Æä¹Ì½ºÅÍ À̽Ä
    ÇÇÁú°ñ ÀÌ½Ä ½Ã¿¡ ÇØ¸é ¼¼Á°ñ À̽ÄÀ» °°ÀÌÇÏ¸é °¡°ñ Çü¼ºÀÌ ÀߵȴÙ.
  • pinch graft
    ÇÉÄ¡ À̽Ä
    Á÷°æ 0.25ÀÎÄ¡ÀÇ ÇÇºÎÆí. ħÀ¸·Î ÇǺθ¦ µé¾î¿Ã·Á Ä®·Î ¾ã°Ô Àß¶ó¼­ ¾ò´Â´Ù. µÎ²²´Â ÀÌ½ÄÆí¸¶´Ù ´Ù¸£³ª Áö¹æÀº ºÙ¾îÀÖÁö ¾Ê´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Fas-activated serine-threonine kinase <enzyme> Phosphorylates tia-1 during fas-mediated apoptosis; contains proline-rich sh3-binding domains; mw 60-63 kD; genbank x86779
Registry number: EC 2.7.10.-
Synonym: fast kinase
(26 Jun 1999)
killer cells, lymphokine-activated Cytolytic lymphocytes with the unique capacity of killing natural killer (nk)-resistant fresh tumour cells. They are interleukin-2-activated nk cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. Lak cells are used for adoptive immunotherapy in cancer patients.
(12 Dec 1998)
fluorescence-activated cell sorter <technique> Flow cytometry is an emerging technique which holds great promise for the separation, classification and quantitation of blood cells and antibodies which affect blood cells.
Complex computerised instruments are used to pass a monocellular stream of cells, platelets or other microscopic particulate elements through a beam of laser light. The cells are categorised first by size and then computer analysed to sort the mixture of cellular elements into cell type by size.
Cells are labelled with fluorescent dye and then passed, in suspending medium, through a narrow dropping nozzle so that each cell is in a small droplet. A laser based detector system is used to excite fluorescence and droplets with positively fluorescent cells are given an electric charge. Charged and uncharged droplets are separated as they fall between charged plates and so collect in different tubes. The machine can be used either as an analytical tool, counting the number of labelled cells in a population or to separate the cells for subsequent growth of the selected population. Further sophistication can be built into the system by using a second laser system at right angles to the first to look at a second fluorescent label or to gauge cell size on the basis of light scatter. The great strength of the system is that it looks at large numbers of individual cells and makes possible the separation of populations with, for example: particular surface properties.
Tabulation of counted data in conjunction with size analysis enables determination of relative percentages of each specific cellular subset for which monoclonal antibody conjugates are utilised, even when the size of the cell is identical to other subset species.
Flow cytometry is a slightly imprecise but common term for the use of the Fluorescence-activated Cell Sorter (FACS).
(01 Dec 1998)
fluorescence-activated cell sorting <technique> A technique for separating and sorting cells marked with a fluorescent label based on how much they fluoresce at a particular wavelength.
(12 Jan 1998)
light-activated resin A resin which uses visible or ultraviolet light to excite a photoinitiator which interacts with an amine to form free radicals and initiate polymerization. Used mainly in restorative dentistry.
Synonym: light-activated resin.
(05 Mar 2000)
accordion graft A skin graft in which multiple slits have been made, so it can be stretched to cover a large area.
Synonym: mesh graft.
(05 Mar 2000)
adipodermal graft A dermal graft with attached subcutaneous fat.
Synonym: adipodermal graft.
(05 Mar 2000)
allogeneic graft <haematology> Grafts between two or more individuals allogeneic at one or more loci (usually with reference to histocompatibility loci). As opposed to autograft and xenograft.
(18 Nov 1997)
anastomosed graft A graft in which circulation is established by surgical anastomoses of blood vessels.
(05 Mar 2000)
animal graft A graft of tissue from an animal to a human.
Synonym: animal graft, zooplastic graft.
(05 Mar 2000)
augmentation graft A graft of material used to increase the size, shape, or volume of a structure.
(05 Mar 2000)
autodermic graft A skin autograft.
(05 Mar 2000)
autogeneic graft <procedure> Graft taken from one part of the body and placed in another site on the same individual.
(02 Jan 1998)
autologous graft <procedure> Graft taken from one part of the body and placed in another site on the same individual.
(02 Jan 1998)
autoplastic graft <procedure> Graft taken from one part of the body and placed in another site on the same individual.
(02 Jan 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á